Cargando…
Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction
BACKGROUND: In 2003, artesunate-amodiaquine (AS+AQ) was introduced as the new first-line treatment for uncomplicated malaria in Burundi. After confirmed diagnosis, treatment was delivered at subsidized prices in public health centres. Nine months after its implementation a study was carried out to a...
Autores principales: | Gerstl, Sibylle, Cohuet, Sandra, Edoh, Kodjo, Brasher, Christopher, Lesage, Alexandre, Guthmann, Jean-Paul, Checchi, Francesco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948001/ https://www.ncbi.nlm.nih.gov/pubmed/17640357 http://dx.doi.org/10.1186/1475-2875-6-94 |
Ejemplares similares
-
Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi
por: Amuasi, John H, et al.
Publicado: (2011) -
“Ways and channels for voice regarding perceptions of maternal health care services within the communities of the Makamba and Kayanza provinces in the Republic of Burundi: an exploratory study”
por: Niyongabo, Prosper, et al.
Publicado: (2018) -
Fixed dose artesunate amodiaquine – a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine
por: Ogutu, Bernhards, et al.
Publicado: (2014) -
Population pharmacokinetics of artesunate and amodiaquine in African children
por: Stepniewska, Kasia, et al.
Publicado: (2009) -
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis
por: Zwang, Julien, et al.
Publicado: (2009)